{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:37:36Z","timestamp":1778254656006,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jacl.2015.03.012","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T15:51:41Z","timestamp":1428681101000},"page":"559-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Medical nutrition therapy is the essential cornerstone for effective treatment of \u201crefractory\u201d severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program"],"prefix":"10.1016","volume":"9","author":[{"given":"Katherine S.","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Marchlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvyn","family":"Rubenfire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Brook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.03.012_bib1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.03.012_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacl.2012.04.003","article-title":"Treatment options for the management of hypertriglyceridemia: strategies based on the best available evidence","volume":"6","author":"Maki","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.jacl.2015.03.012_bib3","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.03.012_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2015.03.012_bib5","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.03.012_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacl.2009.09.003","article-title":"Efficacy and tolerability of multidrug therapy for hypertriglyceridemia","volume":"3","author":"Polansi","year":"2009","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.03.012_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","article-title":"Issues in hyperlipidemic pancreatitis","volume":"36","author":"Yadav","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jacl.2015.03.012_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinternmed.2008.599","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults","volume":"169","author":"Ford","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2015.03.012_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MPA.0b013e31816074a1","article-title":"Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia","volume":"37","author":"Lloret Linares","year":"2008","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.jacl.2015.03.012_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncpendmet0025","article-title":"Severe hypertriglyceridemia with a history of treatment failure","volume":"1","author":"Capell","year":"2005","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jacl.2015.03.012_bib11","first-page":"1365","article-title":"Management of hypertriglyceridemia","volume":"75","author":"Oh","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jacl.2015.03.012_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","volume":"10","author":"Sandhu","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.jacl.2015.03.012_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004836-200204000-00020","article-title":"Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis","volume":"34","author":"Athyros","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jacl.2015.03.012_bib14","unstructured":"Disorders of Lipid Metabolism. Evidenced-based Nutrition Practice Guideline. Academy of Nutrition and Dietetics. Available at: http:\/\/www.adaevidencelibrary.com\/topic.cfm?cat=4527&auth=. Accessed December 16,\u00a02014."},{"key":"10.1016\/j.jacl.2015.03.012_bib15","series-title":"Exchange lists for meal planning","year":"1995"},{"key":"10.1016\/j.jacl.2015.03.012_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2143(98)90168-8","article-title":"Low-density lipoprotein cholesterol can be chemically measured: a new superior method","volume":"132","author":"Okada","year":"1998","journal-title":"J Lab Clin Med"},{"issue":"5","key":"10.1016\/j.jacl.2015.03.012_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1: executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.03.012_bib18","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/jn\/134.6.1400","article-title":"Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia","volume":"134","author":"Jacobs","year":"2004","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.jacl.2015.03.012_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/204748730000700506","article-title":"Is there an optimal diet for the hypertriglyceridemic patient?","volume":"7","author":"Kris-Etherton","year":"2000","journal-title":"J Cardiovasc Risk"},{"issue":"11","key":"10.1016\/j.jacl.2015.03.012_bib20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.jacl.2015.03.012_bib21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jacl.2015.03.012_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ddmec.2004.09.012","article-title":"Therapeutic targets in severe hypertriglyceridemia","volume":"1","author":"Capell","year":"2004","journal-title":"Drug Disc Today: Dis Mech"},{"key":"10.1016\/j.jacl.2015.03.012_bib23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1360-0443.2006.01615.x","article-title":"Measuring average alcohol consumption: the impact of including binge drinks in quantity\u2013frequency calculations","volume":"101","author":"Stahre","year":"2006","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jacl.2015.03.012_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MOL.0b013e3283606845","article-title":"Alcohol and plasma triglycerides","volume":"24","author":"Klop","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"10.1016\/j.jacl.2015.03.012_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-157-9-201211060-00011","article-title":"Drug treatment of asymptomatic hypertriglyceridemia to prevent pancreatitis: where is the evidence?","volume":"157","author":"Lederle","year":"2012","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jacl.2015.03.012_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2012.8439","article-title":"Lipid-modifying therapies and risk of pancreatitis: a meta-analysis","volume":"308","author":"Preiss","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.03.012_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jacl.2012.03.002","article-title":"Hospital use and medical care costs up to 5 years after triglyceride lowering among people with severe hypertriglyceridemia","volume":"6","author":"Nicholas","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.03.012_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacl.2012.08.007","article-title":"Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg\/dL in patients with severe hypertriglyceridemia","volume":"6","author":"Christian","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.03.012_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjmed.2013.09.018","article-title":"Determining triglyceride reduction needed for clinical impact in severe hypertriglyceridemia","volume":"127","author":"Christian","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2015.03.012_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000138126","article-title":"Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid self-monitoring","volume":"52","author":"Hauenschild","year":"2008","journal-title":"Ann Nutr Metab"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T03:06:31Z","timestamp":1566529591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1933287415000999"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.03.012","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical nutrition therapy is the essential cornerstone for effective treatment of \u201crefractory\u201d severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}